Teleperformance


Q326 Trading Update: Weak Top-Line Performance Reinforces Concerns Over Growth Recovery

06/11/26 -"Teleperformance’s Q326 trading update is clearly disappointing, with persistent top-line weakness prompting a significant downgrade to FY26 revenue guidance (-1.5% to -2.5% LFL). Although ..."

Pages
49
Language
English
Published on
06/11/26
You may also be interested by these reports :
06/11/26
Teleperformance’s Q326 trading update is clearly disappointing, with persistent top-line weakness prompting a significant downgrade to FY26 revenue ...

23/10/26
SGS’ Q3 revenues were modestly above expectations, led by a solid contribution from scope and stable organic growth. The beat, however, was largely ...

22/10/26
Rentokil Initial’s Q3’26 organic revenue growth of 3.4% was in line with expectations, with FY26 profit guidance reiterated. Improving contract ...

21/10/26
Eurofins Scientific posted a slight beat on organic growth and revenues, supported by continued strong growth in C&T Product Testing and an ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO